BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 28174420)

  • 1. Clonal evolution of colorectal cancer in IBD.
    Choi CR; Bakir IA; Hart AL; Graham TA
    Nat Rev Gastroenterol Hepatol; 2017 Apr; 14(4):218-229. PubMed ID: 28174420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer in patients with inflammatory bowel disease.
    Vagefi PA; Longo WE
    Clin Colorectal Cancer; 2005 Jan; 4(5):313-9. PubMed ID: 15663834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Colitis to Cancer: An Evolutionary Trajectory That Merges Maths and Biology.
    Al Bakir I; Curtius K; Graham TA
    Front Immunol; 2018; 9():2368. PubMed ID: 30386335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colorectal tumor evolution in inflammatory bowel disease : Dynamics of genomic alterations and potential molecular markers to predict malignant progression].
    Hirsch D
    Pathologe; 2019 Dec; 40(Suppl 3):232-238. PubMed ID: 31811372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia.
    Singhi AD; Waters KM; Makhoul EP; Parian A; Lazarev MG; Proksell SS; Dueker JM; Schwartz MB; Wald AI; Nikiforova MN; Montgomery EA
    Hum Pathol; 2021 Jun; 112():9-19. PubMed ID: 33727167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor grade.
    Pugliese D; Armuzzi A; Castri F; Benvenuto R; Mangoni A; Guidi L; Gasbarrini A; Rapaccini GL; Wolf FI; Trapani V
    Dig Liver Dis; 2020 Oct; 52(10):1188-1194. PubMed ID: 32505565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas.
    Wanders LK; Cordes M; Voorham Q; Sie D; de Vries SD; d'Haens GRAM; de Boer NKH; Ylstra B; van Grieken NCT; Meijer GA; Dekker E; Carvalho B
    Inflamm Bowel Dis; 2020 Jan; 26(2):167-180. PubMed ID: 31372648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.
    M'Koma AE; Moses HL; Adunyah SE
    Int J Colorectal Dis; 2011 May; 26(5):533-52. PubMed ID: 21311893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.
    Cao D; Wilentz RE; Abbruzzese JL; Ho L; Maitra A
    Int J Gastrointest Cancer; 2005; 36(1):39-46. PubMed ID: 16227634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS; Windsor A; Cohen R; Chand M
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
    Du L; Kim JJ; Shen J; Chen B; Dai N
    Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
    Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
    Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
    Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA
    Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
    Yashiro M
    Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.
    Li H; Jin Z; Li X; Wu L; Jin J
    Clin Transl Oncol; 2017 Aug; 19(8):1018-1027. PubMed ID: 28243990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.